Related Experiment Video
Updated: Nov 6, 2025
12:03
Receptor Autoradiography Protocol for the Localized Visualization of Angiotensin II Receptors
Published on: June 7, 2016
18.1K
Mapping Angiotensin II Type 1 Receptor-Biased Signaling Using Proximity Labeling and Proteomics Identifies Diverse
Conrad T Pfeiffer1, Jialu Wang1, Joao A Paulo2
1Department of Medicine, Duke University Medical Center, Durham, North Carolina 27710, United States.
Journal of Proteome Research
|May 5, 2021
Summary
Different ligands activate Angiotensin II type 1 receptors (AT1Rs) differently, influencing their trafficking and signaling pathways. This study reveals unique cellular responses to G-protein-biased versus β-arrestin-biased AT1R ligands.
Area of Science:
- Pharmacology
- Cellular Biology
- Biochemistry
Background:
- Angiotensin II type 1 receptors (AT1Rs) are key G-protein-coupled receptors involved in numerous physiological processes.
- Understanding AT1R signaling diversity is crucial for developing targeted therapeutics.
- Ligand-biased signaling offers a strategy to selectively activate desired downstream pathways.
Purpose of the Study:
- To comprehensively analyze the signaling profiles and trafficking kinetics of AT1Rs in response to various biased ligands.
- To elucidate the distinct cellular mechanisms activated by G-protein-biased versus β-arrestin-biased AT1R agonists.
- To provide a detailed proteomic landscape of AT1R-interacting proteins.
Main Methods:
- Utilized peroxidase-catalyzed proximity labeling to identify proteins interacting with AT1Rs.
- Stimulated cells with six distinct AT1R ligands (full agonist, partial agonist, G-protein-biased, and β-arrestin-biased agonists).
- Analyzed protein proximity labeling at multiple time points (90 s, 10 min, 60 min) and correlated with AT1R trafficking.
Main Results:
- Distinct ligands induced unique AT1R trafficking patterns to different cellular compartments.
- Specific protein classes (GTPases, adaptors, kinases) showed ligand-dependent proximity labeling.
- G-protein-biased ligands preferentially engaged ESCRT-0 complex proteins involved in protein sorting.
- Ligands within the same bias class exhibited similar labeling profiles.
Conclusions:
- AT1R signaling is highly diverse and ligand-dependent, impacting receptor trafficking and downstream activation.
- G-protein-biased and β-arrestin-biased ligands elicit distinct proteomic responses and cellular fates.
- This study provides a detailed map of AT1R signaling networks, crucial for understanding its physiological roles and therapeutic potential.
More Related Videos
Related Concept Videos
01:30Antihypertensive Drugs: Angiotensin II Receptor Blockers
2.0K
In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
2.0K
01:29The Two-State Receptor Model
2.7K
The two-state receptor model explains a drug's interaction with receptors, such as G protein-coupled receptors and ligand-gated ion channels, to induce or inhibit a biological response. When no natural ligands are present, a receptor exists in an equilibrium of inactive (Ri) and active (Ra) conformations. The inactive form does not produce a response, while the active form generates a basal effect known as constitutive activity.
The binding affinity of a drug determines its interaction with...
The binding affinity of a drug determines its interaction with...
2.7K
01:27Transducer Mechanism: Enzyme-Linked Receptors
3.3K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
3.3K
01:25Drug-Receptor Interaction: Agonist
3.3K
Agonists are drugs that interact with specific receptors in the body to produce a biological response. When an agonist binds to a receptor, it activates or enhances the receptor's function, leading to physiological effects. The interaction between agonist drugs and receptors is crucial for their therapeutic action in various medical treatments.
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
3.3K
01:30Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
1.9K
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
1.9K
00:49Ligand Binding and Linkage
5.2K
Allosteric proteins have more than one ligand binding site; the binding of a ligand to any of these sites influences the binding of ligands to the other sites. When a protein is allosteric, its binding sites are called coupled or linked. In the case of enzymes, the site that binds to the substrate is known as the active site and the other site is known as the regulatory site. When a ligand binds to the regulatory site, this leads to conformational changes in the protein that can influence...
5.2K